Literature DB >> 9298894

Lonely no more: p53 finds its kin in a tumor suppressor haven.

M Oren1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298894     DOI: 10.1016/s0092-8674(00)80347-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  16 in total

1.  Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

Authors:  X T Kong; V A Valentine; S T Rowe; M B Valentine; S T Ragsdale; B G Jones; D A Wilkinson; G M Brodeur; S L Cohn; A T Look
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors:  C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.

Authors:  A L Craig; L Burch; B Vojtesek; J Mikutowska; A Thompson; T R Hupp
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

4.  Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved.

Authors:  J T Jan; B H Chen; S H Ma; C I Liu; H P Tsai; H C Wu; S Y Jiang; K D Yang; M F Shaio
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?

Authors:  J Bian; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  HER2 expression and its clinicopathological features in resectable gastric cancer.

Authors:  Yoshiki Kataoka; Hiroshi Okabe; Akihiko Yoshizawa; Sachiko Minamiguchi; Kenichi Yoshimura; Hironori Haga; Yoshiharu Sakai
Journal:  Gastric Cancer       Date:  2012-03-14       Impact factor: 7.370

7.  p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.

Authors:  F Vikhanskaya; M D'Incalci; M Broggini
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

8.  Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1.

Authors:  Jiliang Zhou; Guoqing Hu; Xiaobo Wang
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

9.  Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.

Authors:  J Roth; C König; S Wienzek; S Weigel; S Ristea; M Dobbelstein
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  p53 regulates myogenesis by triggering the differentiation activity of pRb.

Authors:  A Porrello; M A Cerone; S Coen; A Gurtner; G Fontemaggi; L Cimino; G Piaggio; A Sacchi; S Soddu
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.